A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in Hospitals

被引:62
作者
Akpan, Mary Richard [1 ]
Ahmad, Raheelah [2 ]
Shebl, Nada Atef [1 ]
Ashiru-Oredope, Diane [3 ]
机构
[1] Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield AL10 9AB, Herts, England
[2] Univ London Imperial Coll Sci Technol & Med, NIHR Hlth Protect Res Unit Healthcare Associated, Hammersmith Campus,Du Cane Rd, London W12 0NN, England
[3] Publ Hlth England, Antimicrobial Resistance Program, London NW9 5EQ, England
来源
ANTIBIOTICS-BASEL | 2016年 / 5卷 / 01期
关键词
quality indicators; patient; antimicrobial resistance; outcome; antimicrobial stewardship; infectious diseases; CLOSTRIDIUM-DIFFICILE INFECTIONS; HEALTH-CARE EPIDEMIOLOGY; INTERRUPTED TIME-SERIES; HIGH-RISK ANTIBIOTICS; MULTIDISCIPLINARY APPROACH; PRESCRIBING PRACTICE; RESISTANCE PATTERNS; RESTRICTION POLICY; ECONOMIC OUTCOMES; DISEASES SOCIETY;
D O I
10.3390/antibiotics5010005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The growing problem of antimicrobial resistance (AMR) has led to calls for antimicrobial stewardship programs (ASP) to control antibiotic use in healthcare settings. Key strategies include prospective audit with feedback and intervention, and formulary restriction and preauthorization. Education, guidelines, clinical pathways, de-escalation, and intravenous to oral conversion are also part of some programs. Impact and quality of ASP can be assessed using process or outcome measures. Outcome measures are categorized as microbiological, patient or financial outcomes. The objective of this review was to provide an overview of quality measures for assessing ASP and the reported impact of ASP in peer-reviewed studies, focusing particularly on patient outcomes. A literature search of papers published in English between 1990 and June 2015 was conducted in five databases using a combination of search terms. Primary studies of any design were included. A total of 63 studies were included in this review. Four studies defined quality metrics for evaluating ASP. Twenty-one studies assessed the impact of ASP on antimicrobial utilization and cost, 25 studies evaluated impact on resistance patterns and/or rate of Clostridium difficile infection (CDI). Thirteen studies assessed impact on patient outcomes including mortality, length of stay (LOS) and readmission rates. Six of these 13 studies reported non-significant difference in mortality between pre- and post-ASP intervention, and five reported reductions in mortality rate. On LOS, six studies reported shorter LOS post intervention; a significant reduction was reported in one of these studies. Of note, this latter study reported significantly (p < 0.001) higher unplanned readmissions related to infections post-ASP. Patient outcomes need to be a key component of ASP evaluation. The choice of metrics is influenced by data and resource availability. Controlling for confounders must be considered in the design of evaluation studies to adequately capture the impact of ASP and it is important for unintended consequences to be considered. This review provides a starting point toward compiling standard outcome metrics for assessing ASP.
引用
收藏
页数:16
相关论文
共 84 条
[1]   A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking [J].
Aldeyab, Mamoon A. ;
McElnay, James C. ;
Scott, Michael G. ;
Lattyak, William J. ;
Elhajji, Feras W. Darwish ;
Aldiab, Motasem A. ;
Magee, Fidelma A. ;
Conlon, Geraldine ;
Kearney, Mary P. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (04) :1132-1141
[2]   An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings [J].
Aldeyab, Mamoon A. ;
Kearney, Mary P. ;
Scott, Michael G. ;
Aldiab, Motasem A. ;
Alahmadi, Yaser M. ;
Elhajji, Feras W. Darwish ;
Magee, Fidelma A. ;
McElnay, James C. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (12) :2988-2996
[3]   The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings [J].
Aldeyab, Mamoon A. ;
Harbarth, Stephan ;
Vernaz, Nathalie ;
Kearney, Mary P. ;
Scott, Michael G. ;
Elhajji, Feras W. Darwish ;
Aldiab, Motasem A. ;
McElnay, James C. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (01) :171-179
[4]  
Almirante Benito, 2013, Enferm Infecc Microbiol Clin, V31 Suppl 4, P56, DOI 10.1016/S0213-005X(13)70134-4
[5]   The Impact of a Nationwide Antibiotic Restriction Program on Antibiotic Usage and Resistance against Nosocomial Pathogens in Turkey [J].
Altunsoy, Adalet ;
Aypak, Cenk ;
Azap, Alpay ;
Ergonul, Onder ;
Balik, Ismail .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2011, 8 (04) :339-344
[6]  
[Anonymous], 2012, HOSP PHARM, DOI DOI 10.1310/hpj4708-608
[7]  
[Anonymous], 2012, WHO Collaborating Centre for Drug Statistics Methodology
[8]  
[Anonymous], ANT RES SURV EUR
[9]  
[Anonymous], 2014, Antimicrobial resistance: global report on surveillance
[10]   Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis [J].
Ansari, F ;
Gray, K ;
Nathwani, D ;
Phillips, G ;
Ogston, S ;
Ramsay, C ;
Davey, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :842-848